Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
Clinical trial NCT04140201 · UNKNOWN
Trial details
- NCT number
- NCT04140201
- Sponsor
- Alaa Hassan ElBaz
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.